期刊文献+

脂蛋白肾病1例报告及文献复习 被引量:4

A case of lipoprotein glomerulopathy and a literature review of the subject
下载PDF
导出
摘要 回顾性分析2011年6月在中南大学湘雅二医院诊断的1例脂蛋白肾病的临床表现、实验室以及肾活检病理检查结果。本病例以肾病综合征为主要临床表现,实验室检查有血浆载脂蛋白(apo)E和apoB升高,肾活检光镜显示肾小球毛细血管呈血管瘤样扩张,管腔内充满淡染的板层状空泡样物质;免疫组织化学测定显示毛细血管腔内apoE染色阳性;透射电镜显示毛细血管腔内充满大小不一的空泡样脂肪凝聚物,呈簇状或层状排列。脂蛋白肾病无特异性临床表现,诊断脂蛋白肾病除根据临床表现外,还应结合肾脏病理检查,特征性的病理表现在诊断脂蛋白肾病中起重要作用。 To improve the understanding of lipoprotein glomerulopathy, the clinical data of a single case of lipoprotein glomerulopathy, diagnosed at the Second Xiangya Hospital, Central South University in June 2011, were retrospectively analyzed. The analysis included clinical manifestation, laboratory results, and pathological information on kidney biopsy. Nephrotic syndrome was seen as the major clinical feature in this patient. Levels of serum apoE and apoB were increased. Obvious expansion of glomerular capillary cavities, filled with a weakly stained thrombus-like substance, were observed. ApoE immunohistochemical staining showed positive staining in capillary luminal contents. Transmission electron microscopy revealed capillary lurnina occluded by various foaming lipid depositions in clustered or layered arrangement. There were no special symptoms nor obvious abnormal laboratory results of the LPG patient. Diagnosis of LPG should be based on clinical manifestations and renal biopsy. Gharacteristic pathological performance plays an important role in the diagnosis oflipoprotein glomerulopathy.
作者 胡华 张新民
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2012年第3期320-324,共5页 Journal of Central South University :Medical Science
关键词 脂蛋白肾病 载脂蛋白E 临床表现 病理特征 lipoprotein glomerulopathy apoE clinical manifestation pathological characteristic
  • 相关文献

参考文献18

  • 1Saito T,Sato H,Kudo K. Lioprotein glomerulopathy:glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia[J].American Journal of Kidney Diseases,1989,(02):148-153.
  • 2Oikawa S,Matsunaga A,Saito T. Apolipoprotein E Sendai(arginine 145 proline):a new variant associated with lipoprotein glomerulopathy[J].Journal of the American Society of Nephrology,1997,(05):820-823.
  • 3陈育青,张宏,朱世乐,邹万忠,王梅,刘章锁,王海燕.载脂蛋白E上3个氨基酸缺失-脂蛋白肾病相关的基因突变[J].中华医学杂志,2003,83(9):774-777. 被引量:16
  • 4Ishigaki Y,Oikawa S,Suzuki T. Virus-mediated transduction of apolipoprotein E(ApoE)-sendai develops lioprotein glomerulopathy in ApoE-deficient mice[J].Journal of Biological Chemistry,2000,(40):31269-31273.doi:10.1074/jbc.M005906200.
  • 5Russi G,Furci L,Leonelli M. Lipoproteinglomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system):a case report[J].J Med Case Reports,2009.9311-9316.doi:10.1186/1752-1947-3-9311.
  • 6Bomback AS,Song H,D'Agati VD. A new apolipoprotein E mutation,apoE Las Vegas,in a European-American with lipoprotein glomerulopathy[J].Nephrology Dialysis Transplantation,2010,(10):3442-3446.doi:10.1093/ndt/gfq389.
  • 7Smit M. Genetic heterogenecity in familial dysbetali poproteinemia.The E2 (Lys 146-Gln) variant results in a dominant model of inheretance[J].Journal of Lipid Research,1990,(01):45-53.
  • 8PhamT,Kodvawala A,Hui DY. The receptor binding domain of apolipoprotein E is responsible for its antioxidant activity[J].Biochemistry,2005,(20):7577-7582.doi:10.1021/bi0472696.
  • 9Miyata T,Sugiyama S,Nangaku M. Apolipoprotein E2/E5 variants in lipoprotein glomerulopathy recurred in transplanted kidney[J].Journal of the American Society of Nephrology,1999,(07):1590-1595.
  • 10Hoffmann M,Scharnagl H,Panagiotou E. Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathy[J].Journal of the American Society of Nephrology,2001,(03):524-530.

二级参考文献13

  • 1陈惠萍,黎磊石.脂蛋白肾小球病[J].肾脏病与透析肾移植杂志,1997,6(2):182-184. 被引量:20
  • 2Saito T, Sato H, Kudo K, et al. Lipoprotein glomerulopathy:glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia. Am J Kidney Dis, 1989,13:148-153.
  • 3Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein Eby gene amplification and cleavage with HhaI. J Lipid Res,1990,31: 545-548.
  • 4Weisgraber KH. Apolipoprotein E: structure-function relationships.Adv Protein Chem, 1994, 45:249-302.
  • 5Yang AH, Ng YY, Tarng DC, et al. Association of apolipoprotein epolymorphism with lipoprotein glomerulopathy. Report of 2 cases with a new genotype and comparison of the relative frequencies of apolipoproein Eisoforms in lipoprotein glomerulopathy and in the general populatin. Nephron, 1998,78: 266-270.
  • 6Oikawa S, Matsunaga A, Saito T, et al. Apolipoprotein E Sendai(arginine 145-proline ) : a new variant associated with lipoprotein glomerulopathy. J Am Soc Nephrol, 1997, 8: 820-823.
  • 7Matsunaga A, Sasaki J, Komatsu T, et al. A novel apolipoprotein E mutation, E2 (Arg25Gys), in lipoprotein glomerulopathy. Kidney Int, 1999, 56: 421-427.
  • 8Konishi K, Saruta T, Kuramochi S, et al. Association of a novel 3amino acid deletion mutation of apolipoprotein E (apoE Tokyo ) with lipoprotein glomerulopathy. Nephron, 1999,83:214-218.
  • 9Ando M, Sasaki J, Hua H, et al. A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy. Kidney Int, 1999, 56, 1317-1323.
  • 10Ogawa T, Maruyama K, Hattori H, et al. A new variant of apolipoprotein E (apo E Maebashi ) in lipoprotein glomerulopathy.Pediatr Nephrol, 2000,14:149-151.

共引文献22

同被引文献56

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部